Thompson A M AM

Show results for

Unknown (1513)
Genomics (65)
Transcriptomics (31)
Proteomics (25)
Metabolomics (5)
Genomic (1)

Organisms

Homo sapiens (96)
Oikopleura dioica (2)
Candida albicans (2)
Saccharomyces cerevisiae (2)
Mus musculus (2)
Saccharomyces paradoxus (1)
Saccharomyces mikatae (1)
Lachancea waltii (1)
Debaryomyces hansenii (1)
Kluyveromyces lactis (1)
Yarrowia lipolytica (1)
Medicago truncatula (1)
Zea mays (1)
Arabidopsis thaliana (1)
Pseudomonas putida KT2440 (1)
Fasciola hepatica (1)

Repository

EGA (61)
biostudies-arrayexpress (33)
pride (22)
MetaboLights (4)
ENA (2)
dbGaP (1)
GNPS (1)
jPOST (1)
MassIVE (1)
PanoramaPublic (1)

Tissue

Cell culture (10)
Blood (2)
Fibroblast (2)
Neutrophil (2)
B cell (1)
Brain (1)
Breast (1)
Cell suspension culture (1)
Heart (1)
Hepatocyte (1)
Integument (1)
Lymphocyte of B lineage (1)
Permanent cell line cell (1)
Skin (1)
T cell (1)

Disease

Breast cancer (2)
Acute leukemia (1)
Cervix carcinoma (1)
Disease free (1)
Malignant neoplasm of ovary (1)
Neurodevelopmental delay (1)
Osteosarcoma (1)
Pulmonary hypertension (1)

Technology Type

Mass Spectrometry (22)
Illumina 15K (8)
Bottom-up proteomics (7)
Shotgun proteomics (7)
Gel-based experiment (6)
Data-dependent acquisition (4)
Mass spectrometry (3)
Illumina HiSeq 2000 (1)
Illumina HiSeq 2500, Illumina MiSeq (1)
Illumina OncoArray (1)
NMR spectroscopy (1)
Affinity proteomics (1)
Affinity purification coupled with mass spectrometry proteomics (1)
Data-independent acquisition (1)
DiaPASEF (1)
SRM/MRM (1)

Instrument Platform

Q Exactive HF (2)
Liquid Chromatography MS - negative - reverse phase (2)
Bruker (1)
Gas Chromatography MS - (1)
Liquid Chromatography MS - alternating - hilic (1)
Liquid Chromatography MS - alternating - reverse phase (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2010 (16)
2021 (7)
2013 (6)
2020 (5)
2015 (4)
2014 (4)
2022 (4)
2025 (4)
2024 (4)
2012 (2)
2023 (2)
2026 (2)
2011 (1)
2016 (1)

CHEBI ID

CHEBI:24266 (3)
CHEBI:32816 (3)
CHEBI:33508 (3)
CHEBI:133343 (2)
CHEBI:15354 (2)
CHEBI:15428 (2)
CHEBI:15698 (2)
CHEBI:15724 (2)
CHEBI:15729 (2)
CHEBI:15741 (2)
CHEBI:15891 (2)
CHEBI:15978 (2)
CHEBI:16235 (2)
CHEBI:16450 (2)
CHEBI:16634 (2)
CHEBI:166465 (2)
CHEBI:16704 (2)
CHEBI:16708 (2)
CHEBI:16750 (2)
CHEBI:16796 (2)
CHEBI:17012 (2)
CHEBI:17084 (2)
CHEBI:17154 (2)
CHEBI:17234 (2)
CHEBI:17306 (2)
CHEBI:17405 (2)
CHEBI:17505 (2)
CHEBI:17562 (2)
CHEBI:17568 (2)
CHEBI:17596 (2)

Metabolite Name

Glucose (2)
(7Z,10Z)-hexadecadienoylcarnitine (1)
(9Z,12Z)-3-hydroxyhexadecadienoylcarnitine (1)
1,11-Undecanedicarboxylic acid (1)
12-aminododecanoic acid (1)
2-hydroxybenzenesulfonic acid (1)
3-Cresotinic acid (1)
3-Hydroxybenzoic acid (1)
3-Hydroxyoctanoic acid (1)
3-dehydrotetradecasphinganine (1)
4-Pyridoxic acid (1)
5-Oxo-delta-bilirubin (1)
7-oxoglycodeoxycholate (1)
Acetate (1)
Arabinose (1)
Arabitol (1)
Ascorbyl palmitate (1)
Azelaic acid (1)
Benzaldehyde, 2,5-dihydroxy- (1)
Benzoic acid (1)
Benzoic acid, 3,4-dihydroxy- (1)
Bilirubin IXa (1)
Citric acid (1)
Cortisol 21-sulfate (1)
Dopamine (1)
Dopamine 3-O-sulfate (1)
Erythronic acid (1)
Forrnate (1)
Fructose (1)
Fructose-6-phosphate (1)

First Public Date

2014 (2)

Modification

N6 (1)
N6-dimethyl-L-lysine (1)

Study type

Transcription profiling by array (20)
RNA-seq of coding RNA (4)
Methylation profiling by array (2)
RNA-seq of non coding RNA (2)
Transcription profiling by tiling array (1)
Genotyping by array (1)
Other (1)
ChIP-seq (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2022 (169)
2021 (150)
2023 (131)
2024 (125)
2018 (123)
2020 (120)
2025 (109)
2015 (89)
2019 (83)
2016 (75)
2014 (67)
2017 (66)
2013 (48)
2012 (48)
2010 (44)
2011 (33)
2009 (29)
2026 (16)
2008 (13)
2007 (5)
2006 (1)
2004 (1)
2002 (1)

Lab affiliation

Department of Cell Biology, Harvard Medical School, Boston, MA, USA (3)
(Head, NHS Highly Specialised Mitochondrial Diagnostic Laboratory and Professor of Mitochondrial Pathology), Wellcome Centre for Mitochondrial Research, Newcastle University, UK (1)
95 Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UT3), Toulouse, 31077, France (1)
Assistant Professor, Clinical Cancer Prevention, University of Texas MD Anderson Cancer Center (1)
Department of Anesthesiology and Critical Care Medicine Children’s Hospital of Philadelphia University of Pennsylvania Philadelphia, Pennsylvania (1)
Department of Biochemistry, Albert Einstein College of Medicine (1)
Department of Brain Sciences, Division of Neuroscience, Imperial College London, London, UK (1)
Department of Chemistry, The Scripps Research Institute, La Jolla, CA, USA (lab head) (1)
Department of Genome Sciences, University of Washington, USA (1)
Department of Pharmacology, University of North Carolina Chapel Hill School of Medicine, Chapel Hill, NC USA (1)
European Institute of Oncology IRCCS, 20139 Milan, Italy (1)
German Mouse Clinic, Institute of Experimental Genetics, Helmholtz Zentrum München, München, Germany (1)
Head of School, Senior Lecturer, School of Biotechnology, Fundamental and Translational Immunology Group Leader Dublin City University, Dublin 9. Ireland (1)
Highly Specialised Mitochondrial Diagnostic Laboratory, Wellcome Centre for Mitochondrial Research, Newcastle University, UK (1)
Ichan School of Medicine at Mount Sinai (1)
Mitochondrial Research Group, Faculty of Medical Sciences, Newcastle University, UK (1)
School of Biochemistry, University of Bristol, Bristol, United Kingdom (1)
Stanford University, Department of Genetics, United States (1)
Wellcome Centre for Mitochondrial Research, Newcastle University, UK (1)
scripps research institute Cravatt Lab (1)

Tags

xref:PubMed:17419842 (2)

Previous page
1 / 164
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 164
Next page

Sort by:

Relevance

Page size

Historically, did Cemented Thompson perform better than uncemented Austin Moore hemiarthroplasty for femoral neck fractures? A meta-analysis of available evidence.

Not available

S-EPMC6753858 | biostudies-literature

Meloidogyne incognita population control and nutritional status and productivity of Thompson seedless grapevines managed with different treatments.

Not available

S-EPMC7537898 | biostudies-literature

Transient Triplet Metallopnictinidenes M-Pn (M = Pd<sup>II</sup>, Pt<sup>II</sup>; Pn = P, As, Sb): Characterization and Dimerization.

Not available

S-EPMC11826990 | biostudies-literature

Metabonomics uncovers a reversible proatherogenic lipid profile during infliximab therapy of inflammatory bowel disease

BACKGROUND: One-third of inflammatory bowel disease (IBD) patients show no response to infliximab (IFX) induction therapy, and approximately half of patients responding become unresponsive over time. Thus, identification of potential treatment response biomarkers are of great cl...

2022-01-13 | MTBLS239 | MetaboLights

A genetically encoded biosensor reveals spatiotemporal variation in cellular phosphate content in Brachypodium distachyon mycorrhizal roots.

Not available

S-EPMC9790424 | biostudies-literature

Cycles of myofiber degeneration and regeneration lead to remodeling of the neuromuscular junction in two mammalian models of Duchenne muscular dystrophy.

Not available

S-EPMC6209224 | biostudies-literature

Medicago truncatula and Glomus intraradices gene expression in cortical cells harboring arbuscules in the arbuscular mycorrhizal symbiosis.

Not available

S-EPMC2649119 | biostudies-literature

Prospective Study of Psychosocial Outcomes of Having Contralateral Prophylactic Mastectomy Among Women With Nonhereditary Breast Cancer.

Not available

S-EPMC6118404 | biostudies-literature

A polyamine-centric blood-based metabolite panel predictive of poor response to CAR T-cell therapy in large B cell lymphoma

Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy for relapsed or refractory (r/r) large B-cell lymphoma (LBCL) results in durable response in only a subset of patients. MYC overexpression in LBCL tumors is associated with poor response to treatment. We tested whether a MYC-driven polyamin...

2022-10-31 | MTBLS5381 | MetaboLights

An evaluation of whether a gestational weight gain of 5 to 9 kg for obese women optimizes maternal and neonatal health risks.

Not available

S-EPMC6460820 | biostudies-literature

Previous page
1 / 164
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 164
Next page

Sort by:

Relevance

Page size

1640 Results

Show results for

Organisms

Repository

Tissue

Disease

Technology Type

Instrument Platform

Publication Date

CHEBI ID

Metabolite Name

First Public Date

Modification

Study type

Release Date

Lab affiliation

Tags

BACKGROUND: One-third of inflammatory bowel disease (IBD) patients show no response to infliximab (IFX) induction therapy, and approximately half of patients responding become unresponsive over time. Thus, identification of potential treatment response biomarkers are of great cl...

OmicsDI is part of the ELIXIR infrastructure

Tweets